TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 32496286

Group type: EXPERIMENTAL
Intervention: Educational handover describing weaknesses in communication
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Educational handover describing weaknesses in medical expertise
Number of subjects: 72

Group type: COMPARATOR
Intervention: No educational handover (control)
Number of subjects: 72
Study: 34772740

Group type: COMPARATOR
Intervention: Older adults
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Young adults
Number of subjects: 72
Study: 33567928

Group type: COMPARATOR
Intervention: Antiviral drug (oseltamivir) alone
Number of subjects: 284
Study: 33452871

Group type: EXPERIMENTAL
Intervention: Canakinumab treatment
Number of subjects: 0

Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 0
Study: 32107956

Group type: EXPERIMENTAL
Intervention: Serum miR‐125b levels in patients with EOC
Number of subjects: 379

Group type: EXPERIMENTAL
Intervention: Serum miR‐125b levels in patients with high FIGO stage (III+IV)
Number of subjects: 379

Group type: EXPERIMENTAL
Intervention: Serum miR‐125b levels in patients with lymph node metastasis
Number of subjects: 379

Group type: EXPERIMENTAL
Intervention: Serum miR‐125b levels in patients with chemoresistance
Number of subjects: 379

Group type: EXPERIMENTAL
Intervention: Serum miR‐125b levels preoperative vs postoperative
Number of subjects: 379

Group type: EXPERIMENTAL
Intervention: Serum miR‐125b in combination with serum CA125
Number of subjects: 379

Group type: EXPERIMENTAL
Intervention: Low levels of miR‐125b
Number of subjects: 379

Group type: EXPERIMENTAL
Intervention: Sensitivity and specificity of serum miR‐125b
Number of subjects: 379
Study: 36253766

Group type: EXPERIMENTAL
Intervention: Tele-delivered behavioral activation (Tele-BA)
Number of subjects: 277

Group type: EXPERIMENTAL
Intervention: Tele-delivered problem-solving therapy (Tele-PST)
Number of subjects: 277

Group type: COMPARATOR
Intervention: Tele-BA
Number of subjects: 277

Group type: COMPARATOR
Intervention: Attention control (AC)
Number of subjects: 277
Study: 34034766

Group type: EXPERIMENTAL
Intervention: Convolutional neural network model for automated laryngeal mass detection
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Original computer algorithm
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Embedded pilot system for home-based self-screening test
Number of subjects: 0
Study: 32807013

Group type: EXPERIMENTAL
Intervention: 1-Hz rTMS over contralesional M1, 30-minute sessions, 2 weeks duration
Number of subjects: 77

Group type: COMPARATOR
Intervention: Sham rTMS, 30-minute sessions, 2 weeks duration
Number of subjects: 77
Study: 35083965

Group type: EXPERIMENTAL
Intervention: Microneedle fractional radiofrequency (MFR)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Non-ablative 1565 nm fractional laser (NAFL)
Number of subjects: 15

Group type: COMPARATOR
Intervention: NAFL
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: MFR
Number of subjects: 15
Study: 33449527

Group type: EXPERIMENTAL
Intervention: Cellex (0.1 mg daily SC for 10 days)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Cortexin (10 mg per 2 ml of 0.9% NaCl solution IM daily for 10 days)
Number of subjects: 40
Study: 33587381

Group type: EXPERIMENTAL
Intervention: DaxibotulinumtoxinA for Injection (DAXI)
Number of subjects: 2989

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2989
Study: 32654902

Group type: EXPERIMENTAL
Intervention: MCC‐TT (n = 141)
Number of subjects: 284

Group type: EXPERIMENTAL
Intervention: MCC‐CRM (n = 143)
Number of subjects: 284

Group type: EXPERIMENTAL
Intervention: MCC‐TT
Number of subjects: 284

Group type: EXPERIMENTAL
Intervention: MCC‐CRM
Number of subjects: 284

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 284
Study: 36328306

Group type: EXPERIMENTAL
Intervention: Linked-color imaging (LCI)
Number of subjects: 3050

Group type: COMPARATOR
Intervention: White-light imaging (WLI)
Number of subjects: 3050
Study: 33880566

Group type: EXPERIMENTAL
Intervention: MNPs with IYCF counseling
Number of subjects: 4000

Group type: COMPARATOR
Intervention: IYCF counseling only
Number of subjects: 4000
Study: 32000572

Group type: EXPERIMENTAL
Intervention: Very low-carbohydrate high-fat (VLCHF) diet for four weeks
Number of subjects: 18

Group type: COMPARATOR
Intervention: Normal habitual diet (HD)
Number of subjects: 18
Study: 36055183

Group type: EXPERIMENTAL
Intervention: Wheeled Knee Walker (WKW)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Crutches
Number of subjects: 0

Group type: COMPARATOR
Intervention: Walker
Number of subjects: 0
Study: 34591002

Group type: EXPERIMENTAL
Intervention: Preoperative education on opioid use
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: Depression
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: History of prior surgical procedure
Number of subjects: 95
Study: 32799791

Group type: EXPERIMENTAL
Intervention: C-MAC D-Blade videolaryngoscope
Number of subjects: 20

Group type: COMPARATOR
Intervention: Macintosh laryngoscope
Number of subjects: 20
Study: 35860885

Group type: EXPERIMENTAL
Intervention: Milk chocolate
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Dark chocolate
Number of subjects: 20
Study: 34631613

Group type: EXPERIMENTAL
Intervention: Acaricidal bait intervention for 8 weeks
Number of subjects: 66

Group type: COMPARATOR
Intervention: Placebo intervention for 8 weeks
Number of subjects: 66
Study: 35920515

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral program
Number of subjects: 41

Group type: COMPARATOR
Intervention: Routine guidance from the service
Number of subjects: 41
Study: 33029812

Group type: EXPERIMENTAL
Intervention: PDS with calcium concentration of 1.75 mmol/L (high concentration group)
Number of subjects: 102

Group type: COMPARATOR
Intervention: PDS with calcium concentration of 1.25 mmol/L (low concentration group)
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Both groups (low and high calcium)
Number of subjects: 102
Study: 33296583

Group type: EXPERIMENTAL
Intervention: PSS-10
Number of subjects: 535

Group type: EXPERIMENTAL
Intervention: PSS-4
Number of subjects: 535
Study: 35131596

Group type: EXPERIMENTAL
Intervention: Aripiprazole
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: Amisulpride
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: Olanzapine
Number of subjects: 128

Group type: COMPARATOR
Intervention: Antipsychotic-naïve patients
Number of subjects: 128
Study: 32757870

Group type: EXPERIMENTAL
Intervention: Teriparatide (TPTD) for 24 months
Number of subjects: 11

Group type: COMPARATOR
Intervention: Teriparatide (TPTD) for 12 months
Number of subjects: 11
Study: 36069202

Group type: EXPERIMENTAL
Intervention: Sulopenem
Number of subjects: 0

Group type: COMPARATOR
Intervention: Ciprofloxacin
Number of subjects: 0
Study: 33735217

Group type: EXPERIMENTAL
Intervention: Lobectomy
Number of subjects: 14029

Group type: EXPERIMENTAL
Intervention: Limited resection
Number of subjects: 14029

Group type: EXPERIMENTAL
Intervention: Stereotactic body radiation therapy (SBRT)
Number of subjects: 14029

Group type: COMPARATOR
Intervention: Less invasive treatments
Number of subjects: 14029
Study: 35222693

Group type: EXPERIMENTAL
Intervention: Moxibustion
Number of subjects: 104

Group type: COMPARATOR
Intervention: Sham moxibustion
Number of subjects: 104
Study: 32471404

Group type: EXPERIMENTAL
Intervention: Theory-based back care training program (T-Bak) consisting of six sessions on proper lifting, carrying techniques, posture, and backpack wearing
Number of subjects: 104

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 104
Study: 35471469

Group type: EXPERIMENTAL
Intervention: 15 mg/day tolvaptan (TLV) plus original FUR dose for 7 days
Number of subjects: 33

Group type: COMPARATOR
Intervention: 120–200 mg/day furosemide (FUR) for 7 days
Number of subjects: 33
Study: 34187185

Group type: EXPERIMENTAL
Intervention: Liraglutide (1.8 mg once daily for 26 weeks)
Number of subjects: 102

Group type: COMPARATOR
Intervention: Placebo (once daily for 26 weeks)
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Liraglutide
Number of subjects: 102

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Explorative analysis
Number of subjects: 102
Study: 34148643

Group type: EXPERIMENTAL
Intervention: Multimodal protocol combining a motivational interview, subcutaneous injection of NicoSan®, and hyperhydration.
Number of subjects: 554
Study: 33415868

Group type: EXPERIMENTAL
Intervention: Warm acupuncture at Yifeng (TE 17) combined with conventional acupuncture
Number of subjects: 68

Group type: COMPARATOR
Intervention: TDP plus conventional acupuncture
Number of subjects: 68
Study: 35590388

Group type: EXPERIMENTAL
Intervention: 1% topical diclofenac gel
Number of subjects: 264

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 264
Study: 34424331

Group type: EXPERIMENTAL
Intervention: CHW intervention
Number of subjects: 287

Group type: COMPARATOR
Intervention: Usual care control
Number of subjects: 287
Study: 32528409

Group type: EXPERIMENTAL
Intervention: Geriatric multimodal intervention
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: CAPACITY technological ecosystem support
Number of subjects: 0
Study: 33546255

Group type: EXPERIMENTAL
Intervention: multi-domain CCT + PE
Number of subjects: 347

Group type: EXPERIMENTAL
Intervention: two-domain CCT + PE
Number of subjects: 347

Group type: COMPARATOR
Intervention: video watching + PE (control)
Number of subjects: 347
Study: 32901984

Group type: EXPERIMENTAL
Intervention: Internet-based support program
Number of subjects: 258

Group type: EXPERIMENTAL
Intervention: Routine care + Internet-based support program
Number of subjects: 258

Group type: COMPARATOR
Intervention: Routine care
Number of subjects: 258
Study: 34324394

Group type: EXPERIMENTAL
Intervention: Semi-automated software for osteoporosis risk assessment
Number of subjects: 567

Group type: EXPERIMENTAL
Intervention: Fully automated tool for osteoporosis risk assessment
Number of subjects: 567

Group type: EXPERIMENTAL
Intervention: Semi-automated software and fully automated tool
Number of subjects: 567
Study: 34480575

Group type: EXPERIMENTAL
Intervention: SCB-2019 vaccine (3, 9, or 30 µg doses)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 36097167

Group type: EXPERIMENTAL
Intervention: ADT plus abiraterone
Number of subjects: 1125
Study: 34518157

Group type: EXPERIMENTAL
Intervention: 10-week supervised exercise intervention
Number of subjects: 20
Study: 35742477

Group type: EXPERIMENTAL
Intervention: m‐Health app (10,000 steps/day)
Number of subjects: 130

Group type: COMPARATOR
Intervention: Control group (information related to daily recommended PA levels)
Number of subjects: 130
Study: 33706084

Group type: EXPERIMENTAL
Intervention: Atorvastatin 80 mg
Number of subjects: 9980

Group type: COMPARATOR
Intervention: Atorvastatin 10 mg
Number of subjects: 9980
Study: 32641376

Group type: EXPERIMENTAL
Intervention: Dapagliflozin
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 36478528

Group type: EXPERIMENTAL
Intervention: Follitropin delta 12 μg
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Follitropin delta 18 μg
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Follitropin delta 24 μg
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Follitropin delta (all doses)
Number of subjects: 24
Study: 33799044

Group type: EXPERIMENTAL
Intervention: CORT (20mg oral cortisol)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 75
Study: 33025815

Group type: EXPERIMENTAL
Intervention: Radial access
Number of subjects: 44804

Group type: COMPARATOR
Intervention: Femoral access
Number of subjects: 44804
Study: 35477898

Group type: EXPERIMENTAL
Intervention: 30-minute Stroop task to induce mental fatigue (MF)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Watching a documentary for 30 minutes (control)
Number of subjects: 17
Study: 34176392

Group type: EXPERIMENTAL
Intervention: Balovaptan (10 mg or 50 mg)
Number of subjects: 93

Group type: COMPARATOR
Intervention: Balovaptan (0.5–76 mg single dose; 12–52 mg/day multiple doses for 14 days)
Number of subjects: 93

Group type: COMPARATOR
Intervention: Balovaptan (32 mg single dose)
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: Balovaptan (≤76 mg single dose; ≤52 mg/day multiple doses)
Number of subjects: 93
Study: 32057905

Group type: EXPERIMENTAL
Intervention: Compendial Apparatus IV
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: tiny-TIM system
Number of subjects: 0

Group type: COMPARATOR
Intervention: Compendial Apparatus I and II
Number of subjects: 0
Study: 35397750

Group type: EXPERIMENTAL
Intervention: SG + LC
Number of subjects: 222

Group type: COMPARATOR
Intervention: SG only
Number of subjects: 222

Group type: COMPARATOR
Intervention: Delayed LC
Number of subjects: 222
Study: 34639631

Group type: EXPERIMENTAL
Intervention: Wireless vital parameter continuous monitoring (WVPCM)
Number of subjects: 110

Group type: COMPARATOR
Intervention: Regular monitoring (Control group)
Number of subjects: 110
Study: 34637892

Group type: EXPERIMENTAL
Intervention: Single-implant mandibular overdenture (SIMO)
Number of subjects: 65

Group type: COMPARATOR
Intervention: Conventional complete denture (CCD)
Number of subjects: 65
Study: 33242083

Group type: EXPERIMENTAL
Intervention: 3-week antibiotic therapy
Number of subjects: 93

Group type: COMPARATOR
Intervention: 6-week antibiotic therapy
Number of subjects: 93
Study: 32611864

Group type: EXPERIMENTAL
Intervention: Zinc oxide-propolis mixture
Number of subjects: 40

Group type: COMPARATOR
Intervention: Zinc oxide eugenol (ZOE)
Number of subjects: 40
Study: 32729721

Group type: EXPERIMENTAL
Intervention: Regular (equal-interval) graph
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Standard Celeration Chart (SCC; semi-log)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Standard Behavior Graph (SBG; semi-log)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: User acceptability
Number of subjects: 72
Study: 34539805

Group type: EXPERIMENTAL
Intervention: ColonVita
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study: 34786853

Group type: EXPERIMENTAL
Intervention: Nurse-led home-based telephone support and home visits (intervention group)
Number of subjects: 172

Group type: COMPARATOR
Intervention: Home visits alone (control group)
Number of subjects: 172
Study: 32160779

Group type: EXPERIMENTAL
Intervention: BioMatrix biolimus-eluting stent (BES)
Number of subjects: 1911

Group type: COMPARATOR
Intervention: Xience everolimus-eluting stent (EES)
Number of subjects: 1911

Group type: COMPARATOR
Intervention: Resolute zotarolimus-eluting stent (ZES)
Number of subjects: 1911
Study: 35164605

Group type: EXPERIMENTAL
Intervention: Supervised exercise program
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Home-based exercise program
Number of subjects: 180

Group type: COMPARATOR
Intervention: Attention-control group
Number of subjects: 180
Study: 32356108

Group type: EXPERIMENTAL
Intervention: 3D laparoscopic distal gastrectomy
Number of subjects: 79

Group type: COMPARATOR
Intervention: 2D laparoscopic distal gastrectomy
Number of subjects: 79
Study: 32422097

Group type: EXPERIMENTAL
Intervention: Fecal microbiota transplantation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 34779070

Group type: EXPERIMENTAL
Intervention: Clinically indicated replacement
Number of subjects: 3050

Group type: COMPARATOR
Intervention: Routine replacement every 96 hours
Number of subjects: 3050
Study: 34528871

Group type: EXPERIMENTAL
Intervention: MHRCT with UA supplementation
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Placebo with MHRCT
Number of subjects: 25

Group type: COMPARATOR
Intervention: Control group (not specified in the abstract)
Number of subjects: 25
Study: 34952402

Group type: EXPERIMENTAL
Intervention: Cervical dilatation ≥ 4 cm on admission
Number of subjects: 6511

Group type: COMPARATOR
Intervention: Cervical dilatation < 4 cm on admission
Number of subjects: 6511
Study: 33819464

Group type: EXPERIMENTAL
Intervention: Mediational Intervention for Sensitizing Caregivers (MISC)
Number of subjects: 119

Group type: COMPARATOR
Intervention: Nutrition, hygiene, and health care training (Control)
Number of subjects: 119
Study: 34062307

Group type: EXPERIMENTAL
Intervention: Active tDCS (anodal transcranial direct current stimulation over the primary motor cortex for 5 consecutive days at 2 mA for 20 min)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sham tDCS (control group)
Number of subjects: 0
Study: 36163873

Group type: EXPERIMENTAL
Intervention: Zanubrutinib (160 mg twice daily)
Number of subjects: 479

Group type: COMPARATOR
Intervention: Bendamustine + Rituximab (BR)
Number of subjects: 479
Study: 33992421

Group type: COMPARATOR
Intervention: Intramuscular progesterone (50 mg daily)
Number of subjects: 1125

Group type: EXPERIMENTAL
Intervention: Combination treatment (200 mg vaginal micronized progesterone twice daily + 50 mg intramuscular progesterone every third day)
Number of subjects: 1125

Group type: EXPERIMENTAL
Intervention: Vaginal progesterone only (200 mg twice daily)
Number of subjects: 1125

Group type: EXPERIMENTAL
Intervention: Vaginal progesterone supplemented with intramuscular progesterone
Number of subjects: 1125
Study: 32780015

Group type: EXPERIMENTAL
Intervention: Trazodone
Number of subjects: 15

Group type: COMPARATOR
Intervention: CBT-I
Number of subjects: 15
Study: 33274901

Group type: EXPERIMENTAL
Intervention: Water deficit (without water for up to 22 days)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Well-watered (watering until field capacity)
Number of subjects: 6
Study: 34130378

Group type: EXPERIMENTAL
Intervention: Teneligliptin 20 mg
Number of subjects: 65

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 65
Study: 33071075

Group type: EXPERIMENTAL
Intervention: Mechanical chest compression device (MCCD)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Manual CPR
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Not applicable (comparison of ROSC)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Not applicable (predictive value of rSO2)
Number of subjects: 75
Study: 35399553

Group type: EXPERIMENTAL
Intervention: Test granola (TG1-3, RAG:SAG ratio 4.5-5.2)
Number of subjects: 160

Group type: COMPARATOR
Intervention: Control granola (CG1-3, RAG:SAG ratio 54.8-69.3)
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Test granola (TG1-3)
Number of subjects: 160

Group type: COMPARATOR
Intervention: Control granola (CG1-3)
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Test granola (TG)
Number of subjects: 160

Group type: COMPARATOR
Intervention: Control granola (CG)
Number of subjects: 160
Study: 34499874

Group type: EXPERIMENTAL
Intervention: Gemcitabine plus ramucirumab (10 mg/kg on day 1 every 3 weeks)
Number of subjects: 161

Group type: COMPARATOR
Intervention: Gemcitabine plus placebo (intravenous placebo on day 1 every 3 weeks)
Number of subjects: 161

Group type: EXPERIMENTAL
Intervention: Gemcitabine plus ramucirumab
Number of subjects: 161

Group type: COMPARATOR
Intervention: Gemcitabine plus placebo
Number of subjects: 161
Study: 32436899

Group type: EXPERIMENTAL
Intervention: Three-dimensional porcine collagen matrix (PCM) with coronally advanced flap (CAF)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Connective tissue graft (CTG) with coronally advanced flap (CAF)
Number of subjects: 20
Study: 36324081

Group type: EXPERIMENTAL
Intervention: 100% FiO2 of HFNC (Group H100)
Number of subjects: 369

Group type: EXPERIMENTAL
Intervention: 50% FiO2 of HFNC (Group H50)
Number of subjects: 369

Group type: COMPARATOR
Intervention: Control group (Group C)
Number of subjects: 369
Study: 33357203

Group type: EXPERIMENTAL
Intervention: Zinc supplementation (0.6 mL/kg/day orally for 10 days) + phototherapy
Number of subjects: 200

Group type: COMPARATOR
Intervention: Phototherapy only
Number of subjects: 200
Study: 36285795

Group type: EXPERIMENTAL
Intervention: Vitamin D3 (2000 IU/d)
Number of subjects: 1025

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1025

Group type: EXPERIMENTAL
Intervention: n-3 fatty acids (1 g/d)
Number of subjects: 1025
Study: 33485336

Group type: EXPERIMENTAL
Intervention: Diet rich in whole grain, fatty fish, nuts, vegetables, and fruit supplemented with probiotics
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control diet resembling average nutritional intake in Sweden
Number of subjects: 50
Study: 36288364

Group type: EXPERIMENTAL
Intervention: Virtually delivered Sudarshan Kriya Yoga (SKY)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Waitlist control
Number of subjects: 0
Study: 34554688

Group type: EXPERIMENTAL
Intervention: High-concentration capsaicin (HCCP) 179 mg (8% w/w) cutaneous patch
Number of subjects: 559

Group type: COMPARATOR
Intervention: Daily oral pregabalin (150-600 mg)
Number of subjects: 559

Group type: EXPERIMENTAL
Intervention: High-concentration capsaicin (HCCP)
Number of subjects: 559
Study: 34124238

Group type: EXPERIMENTAL
Intervention: Mobile application 'little lovely dentist'
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: YouTube® 'dental video songs'
Number of subjects: 160

Group type: COMPARATOR
Intervention: Tell‐show‐do
Number of subjects: 160

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 160
Study: 33542249

Group type: EXPERIMENTAL
Intervention: Spinosad
Number of subjects: 124

Group type: EXPERIMENTAL
Intervention: S‐1,2‐di(ethoxycarbonyl) ethyl 0,0‐dimethylphosphorodithioate (chemical control)
Number of subjects: 124

Group type: EXPERIMENTAL
Intervention: Lecanicillium lecanii
Number of subjects: 124

Group type: EXPERIMENTAL
Intervention: Beauveria bassiana
Number of subjects: 124

Group type: EXPERIMENTAL
Intervention: Mix of B. bassiana and B. brongniartii
Number of subjects: 124

Group type: EXPERIMENTAL
Intervention: Cultural management (pruning and keeping area clear of weeds)
Number of subjects: 124

Group type: COMPARATOR
Intervention: Control (distilled water)
Number of subjects: 124
Study: 33736745

Group type: EXPERIMENTAL
Intervention: Motivational Interviewing (MI)
Number of subjects: 147

Group type: COMPARATOR
Intervention: Supportive Counselling (Control)
Number of subjects: 147
Study: 32096706

Group type: EXPERIMENTAL
Intervention: Deep learning classifier for NAFLD diagnosis (MRI PDFF ≥ 5%)
Number of subjects: 204

Group type: EXPERIMENTAL
Intervention: Fat fraction estimator predicting MRI PDFF
Number of subjects: 204
Study: 32146074

Group type: EXPERIMENTAL
Intervention: Progressive Muscle Relaxation (PMR)
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: Virtual Reality (VR)
Number of subjects: 93

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 93
Study: 36347276

Group type: EXPERIMENTAL
Intervention: HAL spectacles
Number of subjects: 119

Group type: COMPARATOR
Intervention: SV spectacles
Number of subjects: 119
Study: 32211758

Group type: EXPERIMENTAL
Intervention: HIV‐ASSIST
Number of subjects: 118

Group type: COMPARATOR
Intervention: DHHS guidelines alone
Number of subjects: 118